Iovance Biotherapeutics Reports Results from FDA End of Phase 2 meeting and Provides Updates About the Company’s Clinical Program Read more about Iovance Biotherapeutics Reports Results from FDA End of Phase 2 meeting and Provides Updates About the Company’s Clinical Program
Iovance Biotherapeutics to Present at the 2018 Cantor Global Healthcare Conference Read more about Iovance Biotherapeutics to Present at the 2018 Cantor Global Healthcare Conference
Iovance Biotherapeutics to Present at Two Investor Conferences in September Read more about Iovance Biotherapeutics to Present at Two Investor Conferences in September
Iovance Biotherapeutics Announces Clinical Trial Updates with Collaborators MD Anderson and Moffitt Cancer Center Read more about Iovance Biotherapeutics Announces Clinical Trial Updates with Collaborators MD Anderson and Moffitt Cancer Center
Iovance Biotherapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update Read more about Iovance Biotherapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
Iovance Biotherapeutics to Host Second Quarter 2018 Financial Results Conference Call and Webcast on Monday, August 6, 2018 Read more about Iovance Biotherapeutics to Host Second Quarter 2018 Financial Results Conference Call and Webcast on Monday, August 6, 2018
Iovance Biotherapeutics Announces First Patient Dosed in Europe for Ongoing C-144-01 Phase 2 Trials in Metastatic Melanoma Read more about Iovance Biotherapeutics Announces First Patient Dosed in Europe for Ongoing C-144-01 Phase 2 Trials in Metastatic Melanoma
Iovance Biotherapeutics to Present at Two Investor Conferences in June Read more about Iovance Biotherapeutics to Present at Two Investor Conferences in June
Iovance Biotherapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update Read more about Iovance Biotherapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
Iovance Biotherapeutics to Host First Quarter 2018 Financial Results Conference Call and Webcast on Thursday, May 10, 2018 Read more about Iovance Biotherapeutics to Host First Quarter 2018 Financial Results Conference Call and Webcast on Thursday, May 10, 2018